Joshua Taylor, DO
Psychiatry · Erie, PANPI 1821559899
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $679 of the $779 with a category attached, or 87.2%. It is spread thinly across 14 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $537 and has fallen 73.5% since, to $142 in 2025.
Across 37 payments — averaging $21.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$172
- Harmony Biosciences LLC$100
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$100
- Takeda Pharmaceuticals U.S.A., Inc.$75
- Lundbeck LLC$67
- Vanda Pharmaceuticals Inc.$65
- plus $201 from 8 others
What the payments were for
- Food & beverage$67987%
- Education$10013%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$779 in reported general payments places this provider in the 70th percentile of 1,838 psychiatry providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 51 | $946 |
| Sertraline Hcl | 62 | $604 |
| Quetiapine Fumarate | 32 | $340 |
| Fluoxetine Hcl | 51 | $314 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 27 | $220 |
| Bupropion XlBupropion Hcl | 23 | $210 |
| Buspirone Hcl | 22 | $156 |
| Aripiprazole | 28 | $138 |
| Lorazepam | 44 | $117 |
| Escitalopram Oxalate | 15 | $84 |
| Alprazolam | 32 | $72 |
| Trazodone Hcl | 20 | $62 |
| Risperidone | 19 | $54 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 11 | $1 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Erie
- Mary Anne AlbaughErie$24K
- Lance BesnerErie$17K
- Sean SuErie$16K
- Rebecca RomaPittsburgh$3.3M
- Robert NelsonWyomissing$2.2M
- Matthew BergerMoosic$1.7M
- Mark MattaNew Castle$847K
- Mayer AyyashPittsburgh$714K
- Daniel WeintraubPhiladelphia$647K
- Sachin MehtaBlue Bell$646K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.